Stocks
Jazz Pharmaceuticals plcJAZZ
NASDAQHealthcareBiotechnology$178.55-0.98%
A biopharmaceutical company focused on developing and commercializing innovative medicines for serious diseases, with a strong portfolio in sleep disorders and oncology. Investors track Jazz Pharmaceuticals for its specialty drug pipeline and recent acquisitions expanding its hematology/oncology footprint.
Market Cap: $11.0B52W Range: $95.49 – $198.00
Congressional Interest in Jazz Pharmaceuticals plc (JAZZ)
11 members of Congress have disclosed 14 trades in Jazz Pharmaceuticals plc (JAZZ), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
11
Buys
6
Sells
8
Who in Congress Is Trading JAZZ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-04-19 | SHELLEY BERKLEY | sell | 2,886.31 |
| 2023-07-12 | Daniel Goldman | sell | $15K – $50K |